Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient9s disease pathophysiology. The company developed the OptiMap 34 System, a 510(k) cleared electrographic flow (EGF) mapping solution designed with AI, enabling physicians to See What Matters.

The OptiMap 34 System is an advanced mapping system that calculates Electrographic Flow 34 (EGF) from unipolar electrogram signals recorded from the 64-electrode OptiMap 34 basket catheter. It uses an innovative optical flow algorithm to enable the full spatiotemporal reconstruction of the chaotic and disorganized electrical conduction of atrial fibrillation, allowing for personalized treatment approaches. The EGF algorithm helps identify active sources and propagation patterns that may represent triggers or drivers of atrial arrhythmias, facilitating improved treatment effectiveness and minimal ablation strategies tailored to each patient.

Cortex leverages multimodal AI in medtech to drive new technologies and impact patient outcomes. Key figures include Dr. Matt Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, who joined Cortex's board, and leading physicians endorsing the OptiMap System's simplicity and potential in complex atrial fibrillation cases.